Skip to content

Read Full Article Here:

In the southern US, Matt Maxwell has been working for months to recruit participants for ongoing Covid-19 vaccine trials.

But the industry behind many vaccine trials is ill-equipped to answer that call.

The work is time-intensive and, having failed to prioritize diversity until now, many organizations running clinical trials are struggling to change their practices under pressure.

But the Covid-19 vaccine trials are the first time a pharmaceutical company has asked her to recruit a demographically representative sample.

AstraZeneca did not respond to requests to provide data on diversity within its Covid-19 vaccine trials.

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *

Related Articles